Literature DB >> 9386228

Pharmaceutical treatment of obesity.

G L Blackburn1, D Miller, S Chan.   

Abstract

The prevalence of obesity in America has increased steadily in the past 7 decades, especially in the last decade. Health factors that lead to obesity are discussed. This article focuses on the treatment of obesity and potential results.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9386228

Source DB:  PubMed          Journal:  Nurs Clin North Am        ISSN: 0029-6465            Impact factor:   1.208


  3 in total

1.  Dose response biology of resveratrol in obesity.

Authors:  Giovanni Scapagnini; Sergio Davinelli; Taku Kaneko; Guido Koverech; Angela Koverech; Edward J Calabrese; Vittorio Calabrese
Journal:  J Cell Commun Signal       Date:  2014-11-12       Impact factor: 5.782

Review 2.  A benefit-risk assessment of sibutramine in the management of obesity.

Authors:  Enzo Nisoli; Michele O Carruba
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

Review 3.  New pharmacological tools for obesity.

Authors:  E Nisoli; M O Carruba
Journal:  J Endocrinol Invest       Date:  2002-11       Impact factor: 4.256

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.